The emergence of peptides in the pharmaceutical business: From exploration to exploitation
This minireview touches upon the challenges and opportunities peptides experience on the track to become an approved pharmaceutical. Peptide attributes originally considered troublesome with respect to drug development may now turn out to be more convenient rather than unfavourable. Besides characte...
Main Authors: | Thomas Uhlig, Themis Kyprianou, Filippo Giancarlo Martinelli, Carlo Alberto Oppici, Dave Heiligers, Diederik Hills, Xavier Ribes Calvo, Peter Verhaert |
---|---|
Format: | Article |
Language: | English |
Published: |
Elsevier
2014-09-01
|
Series: | EuPA Open Proteomics |
Subjects: | |
Online Access: | http://www.sciencedirect.com/science/article/pii/S2212968514000361 |
Similar Items
-
Handbook of solubility data for pharmaceuticals /
by: 509927 Jouyban, Abolghasem
Published: (c201) -
Innovation in Pharmaceutical Assistance
by: Jean Leandro Dos Santos
Published: (2022-07-01) -
2017 FDA Peptide Harvest
by: Othman Al Musaimi, et al.
Published: (2018-05-01) -
Case studies in modern drug discovery and development /
by: Huang, Xianhai, et al.
Published: (c201) -
TIME TO STEP FORWARD HEADED FOR INNOVATION
by: Muhammad Akhlaq
Published: (2014-05-01)